-
Budget Impact Analysis of Noninvasive Tests Strategies for Metabolic Dysfunction-Associated Steatohepatitis (MASH) Diagnosis in Japan
Sep 9, 2025, 16:22 PM -
Delphi Panel for Standardizing Outcome Measures in Radical Prostatectomy Surgical Care Pathway
Sep 9, 2025, 16:22 PM -
Divergent Biologic Price Archetypes: Year-on-Year List Price Evolution Pre- and Post-Biosimilar Entry in the US, Europe, and Japan
Sep 9, 2025, 16:22 PM -
Evaluating the Costs and Benefits of Innovative Pricing and Payment Models in Europe
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Nemolizumab in the Treatment of Patients With Moderate-to-Severe Prurigo Nodularis in Italy
Sep 9, 2025, 16:22 PM -
Access and Evolving Evidence: A European HTA Analysis of Innovative Medicines Under Evidence Generation Agreements
Sep 9, 2025, 16:22 PM -
Navigating Parallel Joint Scientific Consultations Under EU HTA Regulation: Key Internal Considerations for Health Technology Developers
Sep 9, 2025, 16:22 PM -
Systematic Review of the Cost-Effectiveness of Insulin Therapies in the Treatment of Type 2 Diabetes
Sep 9, 2025, 16:22 PM -
Simulation-Guided Trial Planning of a Cluster Randomized Trial With Probabilistic Covariate-Constrained Randomization for Vaccine Coverage
Sep 9, 2025, 16:22 PM -
Extension of the Mammographic Screening Program in Italy: Cost-Benefit Analysis and Impact of Early Diagnosis in the 45-74 Age Group
Sep 9, 2025, 16:22 PM -
Assessing Productivity in Health Technology Assessment: A Comparative Review of Human Capital and Friction Cost Approaches in Europe
Sep 9, 2025, 16:22 PM -
An Algorithm to Identify Immunocompromised Patients in French Claims Data for Rapid Preventive or Therapeutic Interventions
Sep 9, 2025, 16:22 PM -
The Impact of Network Meta-Analyses on HTA Decisions in Oncology: A Review of NICE Appraisals
Sep 9, 2025, 16:22 PM -
Cost of Illness Study: Cushing's Syndrome in the Kingdom of Saudi Arabia
Sep 9, 2025, 16:22 PM -
Real-World Evidence Study on PD-L1 Testing and Use of Immuno-Oncology (IO) Treatments Among Cancer Patients in the Helsinki and Uusimaa (HUS) Region, Finland
Sep 9, 2025, 16:22 PM -
Evaluating High-Cost Gene Therapies for Noncancer Conditions: Insights From NICE's Standard Appraisal Process
Sep 9, 2025, 16:22 PM -
Environmental Impact of Prefilled and Reusable Injectable Systems: A Systematic Review
Sep 9, 2025, 16:22 PM -
Effectiveness of Vonoprazan on Health-Related Quality of Life and Sleep Quality in Chinese Patients With Reflux Esophagitis: Post Hoc Analysis of the VIEW Study
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness and Budget Impact of High-Dose Trivalent Influenza Vaccine Efluelda® in Older Adults: A Greek Healthcare System Perspective
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of LGI-Flag in Austria: A Model-Based Evaluation
Sep 9, 2025, 16:22 PM